Do statins have a beneficial effect on the kidney? Commentary

Nature Clinical Practice Nephrology

Volumn 2, Issue 12, 2006, Pages 666-667

  Levi, Moshe ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EZETIMIBE; PLACEBO; ROSUVASTATIN; SIMVASTATIN; STATIN;

ALBUMINURIA; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; COVARIANCE; CREATININE CLEARANCE; DIABETES MELLITUS; DRUG EFFECT; EMBASE; EXPERIMENTAL MODEL; FOLLOW UP; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MEDLINE; META ANALYSIS; NEPHROLOGY; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; PUBLISHING; REFERENCE DATABASE; REGRESSION ANALYSIS; RENAL PROTECTION; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; URINARY EXCRETION;

EID: 33845241489     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0336     Document Type: Note

References (6)

1. Danesh FR and Kanwar YS (2004) Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy. FASEB J 18: 805-815
2. Campese VM et al. (2005) Are 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors renoprotective? J Am Soc Nephrol 16 (Suppl 1): S11-S17
3. D'Amico G (2006) Statins and renal diseases: from primary prevention to renal replacement therapy. J Am Soc Nephrol 17 (Suppl 2): S148-S152
4. Navaneethan SD et al. (2006) Statins in patients with chronic kidney disease: evidence from systematic reviews and randomized clinical trials. PLoS Med 3: e123
5. Wanner C and Krane V (2006) Lessons learnt from the 4D trial. Nephrol Ther 2: 3-7
6. Kearney PM and Baigent C (2006) Statins: are any questions unanswered? Curr Opin Lipidol 17: 418-425